CD19 and rheumatoid arthritis: Notably, although the sample size of our study is really not large enough to obtain definitive conclusions, we observed that the frequency of CD19+, CD24hiCD38− and CD24hiCD38hi B cells that expressed PD-L1 increased in RA patients with a positive response to treatment.